Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Clinical Trials

Teva Pharma Issues Positive Update from Reslizumab Phase III

Clinical Trials
Teva Pharma announced positive new data from Phase III studies of the company’s anti-IL5 monoclonal antibody, reslizumab, in patients with uncontrolled moderate to severe...

Lilly’s Basal Insulin Peglispro Demonstrated HbA1c Superiority Against Lantus® In Phase III Trials In Patients With Type 1 Diabetes

Clinical Trials
Core Phase III clinical trial program complete; BIL showed consistent HbA1c superiority against comparators Lilly expects U.S. and European regulatory submissions by end of...

Gilenya® data at ACTRIMS-ECTRIMS to show Novartis is redefining MS treatment goals for patients

Clinical Trials
'No evidence of disease activity' (NEDA), the ultimate treatment goal in MS, is currently assessed by measuring relapses, MRI lesions and disability progression New...

ABBOTT RECEIVES CE MARK FOR FREESTYLE® LIBRE, A REVOLUTIONARY GLUCOSE MONITORING SYSTEM FOR PEOPLE WITH DIABETES

Clinical Trials
- FREESTYLE LIBRE SYSTEM ELIMINATES ROUTINE FINGER PRICKS FOR GLUCOSE MEASUREMENTS1 AND REQUIRES NO FINGER PRICKS FOR CALIBRATION - AVAILABLE FOR PEOPLE LIVING WITH...

Novartis to unveil new data from three key clinical trials at European Respiratory Society International Congress 2014

Clinical Trials
First presentation of LANTERN study to confirm superior efficacy of once-daily Ultibro® Breezhaler® versus Seretide® Accuhaler®* in COPD patients QUANTIFY study to show superiority...

Boston Strategics begins Phase I trial of anti-cancer agent to treat haematologic malignancies

Americas
Boston Strategics (BSC) has started a Phase I clinical trial of Fujifilm's anti-cancer agent FF-10501 in the US to treat patients with advanced haematologic...

Exelixis’ Phase III prostate cancer trial of cabozantinib fails to meet primary endpoint

Americas
US-based biopharmaceutical firm Exelixis has reported disappointing top-line results from the final analysis of COMET-1, the Phase III trial of cabozantinib in men with...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

Whitepapers 0
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

Whitepapers 0
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Whitepapers 0
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

About us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

Resources

Advertise

Subscribe

Copyright © Value Media Group 2026. All rights reserved.